Clinical Trials Logo

Clinical Trial Summary

This study will investigate the use of misoprostol for first-line treatment of incomplete abortion at tertiary hospitals in Myanmar.


Clinical Trial Description

This open-label feasibility study seeks to examine the potential of 400μg sublingual misoprostol for the treatment of incomplete abortion provided at tertiary hospitals. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02707653
Study type Interventional
Source Gynuity Health Projects
Contact
Status Completed
Phase N/A
Start date March 2016
Completion date November 2016

See also
  Status Clinical Trial Phase
Completed NCT01939457 - 400mcg Sublingual Misoprostol as First Line Treatment N/A
Recruiting NCT05342467 - Gemeprost Versus Dinoprostone in First Trimester Miscarriages Phase 2
Completed NCT00674232 - Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment N/A
Not yet recruiting NCT05343546 - Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion N/A
Recruiting NCT01775917 - The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception. N/A
Completed NCT00466999 - Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion N/A
Completed NCT01539408 - Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria Phase 1
Completed NCT03622073 - Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda. N/A
Completed NCT01743508 - Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians in Uganda N/A